Israeli pharma company launches drug for H. pylori in US market
Talicia from RedHill Biopharma is the first new FDA-approved drug in more than a decade for the gastrointestinal H. pylori infection in adults.
MARCH 15, 2020, 2:45 PM
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario